Tourette's Syndrome
Medical Education
B.S.: Brigham Young University, Provo, Utah, 1986
Medical Degree: Duke University School of Medicine, Durham, North Carolina, 1990
Residency: Psychiatry, Barnes-Jewish Hospital, Washington University, St. Louis, Missouri, 1994
Fellowship: Movement Disorders and Neuroimaging, Washington University, St. Louis, Missouri, 1996
Honors and Awards
Listed in Best Doctors in America, 2005-2013 (Best Doctors, Inc.)
Listed in America's Top Doctors, 2010-2012 (Castle Connolly LTD.)
Hope Award, St. Louis Chapter of the Huntington Disease Society of America, 2006
Special Certification in Behavioral Neurology & Neuropsychiatry from the United Council for Neurologic Subspecialties
Disclosure of Financial Interests with IndustryWashington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.
Dr. Kevin J. Black reported the following earned financial interests during calendar year 2011. Move your mouse over a header for more info.
| Company | Royalties Royalties: When a faculty member invents or conceives a new or improved process or product, the company that manufactures the product will make royalty payments to the faculty member. Royalty payments usually are a small percentage of the company’s revenue related to that product. | Equity Equity: Equity is an ownership interest in a company. Faculty members may be paid for their service to a company in stock or the option to obtain stock. | Consulting &
Advisory Boards Consulting and Advisory Boards: Faculty may be paid to provide expertise to a company by being their consultant, or by serving on an advisory board. | Speaker Fees Speaker Fees: Companies may pay faculty to speak to professional audiences about their products. |
| Quandyn.com | | Yes | | |
To learn more about Washington University's policies on collaborations with industry,
click here.
Recent or Selected Journal Articles
Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JA, Videen TO, Snyder AZ, Karimi M, Moerlein SM, Black KJ, Perlmutter JS, Hershey T.Characterization of extrastriatal D2 in vivo specific binding of [(18) F](N-methyl)benperidol using PET.
Synapse. 2012 Apr 26. doi: 10.1002/syn.21566. [Epub ahead of print]
Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD, Karimi M, Perlmutter JS, Hershey T.Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2012 Dec 1;24(1):28-36.
Limsoontarakul S, Campbell MC, Black KJ.A perfusion MRI study of emotional valence and arousal in Parkinson's disease. Parkinsons Dis. 2011;2011:742907. Epub 2011 Sep 28.
Perantie DC, Koller JM, Weaver PM, Lugar HM, Black KJ, White NH, Hershey T. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes. 2011 Nov;60(11):3006-14. Epub 2011 Sep 27.
Black KJ, Koller JM, Campbell MC, Gusnard DA, Bandak SI: Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. J Neurosci 2010; 30(48):16284-16292. PubMed
Foster ER, Black KJ, Antenor-Dorsey JAV, Perlmutter JS, Hershey T: Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain Cogn 2008; 67(1):1-10. PubMed or PubMed Central
Wang L, Lee DY, Bailey E, Hartlein J, Gado M, Miller MI, Black KJ: Validity of large-deformation high dimensional brain mapping of the thalamus and basal ganglia in adults with Tourette syndrome. Psychiatry Res Neuroimaging 2007; 154(2):181-190. PubMed or PubMed Central
Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS: Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson disease. Neuropsychopharmacology 2005; 30(3):590-601. PubMed
Hershey T, Black KJ, Hartlein J, Barch DM, Braver TS, Carl JL, Perlmutter JS: Cognitive-pharmacologic fMRI in Tourette syndrome: A pilot study. Biol Psychiatry 2004; 55(9):916-925. PubMed
Invited Publications
Black KJ: Tics. Chapter 385 in Kompoliti K, Verhagen L (eds.), Encyclopedia of Movement Disorders. Oxford: Elsevier (Academic Press), 2010. http://www.elsevier.com/wps/product/cws_home/721402
Black KJ: ‘Stop doing that!’ Recognizing and managing tics. Mo Med 2008; 105(1):53-56. PubMed
Black KJ, Friedman JH: Repetitive and impulsive behaviors in treated Parkinson disease. Neurology 2006; 67(7):1118-1119. PubMed
Black KJ, Pandya A. Depression in Parkinson disease. Pp. 199-237 in Gilliam F, Kanner AM, Sheline YI: Depression and Brain Dysfunction. New York: Taylor & Francis, 2006.
For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Kevin J. Black.